|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 7.01.
|
Regulation FD Disclosure.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit No.
|
Exhibit Description
|
|
Press release dated January 8, 2024, issued by Strata Skin Sciences, Inc.
|
STRATA SKIN SCIENCES, INC.
|
|||
Date: January 8, 2024
|
By:
|
/s/ Christopher Lesovitz
|
|
Christopher Lesovitz
|
|||
Chief Financial Officer
|
● |
Majority of lesions demonstrated ≥50% clearing by 1-2 weeks, exceeding the criteria of ≥30% reduction in lesion size at two follow-up visits.
|
● |
An average reduction in lesion size was rated 2.0 (30-50% reduction) at 24-72 hours post-treatment and 3.5 at 1-2 weeks (≥50-75% reduction).
|
● |
At 1-2 weeks, the most frequently reported event was mild hyperpigmentation; erythema, edema, and flaking were observed in ≤10% of lesions.
|
Document and Entity Information |
Jan. 08, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 08, 2024 |
Entity File Number | 000-51481 |
Entity Registrant Name | STRATA Skin Sciences, Inc. |
Entity Central Index Key | 0001051514 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 13-3986004 |
Entity Address, Address Line One | 5 Walnut Grove Drive |
Entity Address, Address Line Two | Suite 140 |
Entity Address, City or Town | Horsham |
Entity Address, State or Province | PA |
Entity Address, Postal Zip Code | 19044 |
City Area Code | 215 |
Local Phone Number | 619-3200 |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | SSKN |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
RHY_U=3_ 102P,$% @ 08 H6)>*NQS $P( M L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/: (7->=I3W;+T]!;X"O.DQQ0FE( M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'FR-9V87YTC'?8Q']>5=2(6N MF9MYEJ6R!F_236P@R*2*Y U+2X 3[+O,&@EXN1:T/9=1,9 M2L88!.R '<(Y_ A^[<#K3P&]'@!6^A C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$) M'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND M53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R M( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$% @ 08 H M6"0>FZ*M ^ $ !H !X;"]? +7_OR4Z? M:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-D MGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R M&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( M $& *%AED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[# M,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7 MK-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ M*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@ M9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WC MEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2F MKW@ALO7L^T%.6X.^D X M K @ $0 @ &O 9&]C4')O<',O8V]R92YX;6Q02P$" M% ,4 " !!@"A8F5R<(Q & "<)P $P @ ', 0 >&PO M=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( $& *%BWS!@:;00 #X1 8 M " @0T( !X;"]W;W)K &PO M &PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !!@"A899!YDAD! #/ M P $P @ '&$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 1 "0 ) #X" 0% ! end
;HPXZQLZ*?9GOU_/DG
MP]7?M]ZC_C*:?Y'"PL3_QR S0;4=BUCQ1(T+K(T+8*E29"DV!>&0I9I1Y@L!I3<./]^I"3:
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M/A&E.QN^.D=\=29O^.K\N'<>-QG>BM-T3U(_";[O],_J4 SZ17DD
M2O6E[,I43_)#D:H85YCRH7C4YY^C+;\_Y%0?Y4).U(
>[QB:F9N:V=@\?V3LX.GG[^/KY!P0^CO@E,HH0'1.;
M^BPM/2,SZWEV85%QR8O2W\M>UKYZ75??T-C4_+:KNZ>WKW]@<'QB'%K]
MO">,JE<"A>*5G5G/T-)'\K=UY\:*8S^TX@M6[O:N&:ZLA#7:_WF/)W+_%K/U
MO<'